[{"orgOrder":0,"company":"WanBangDe Pharmaceutical","sponsor":"The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"CHINA","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Ginkgo Biloba","moa":"Sodium-dependent noradrenaline transporter; Phospholipase A2, membrane associated; Glycine receptor subunit alpha-1; Gamma-aminobutyric acid receptor subunit alpha-1; Gamma-aminobutyric acid receptor subunit beta-2; Gamma-aminobutyric acid receptor subunit gamma-2; Amine oxidase [flavin-containing] A; Nitric oxide synthase, inducible","graph1":"Psychiatry\/Psychology","graph2":"Phase IV","graph3":"WanBangDe Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"WanBangDe Pharmaceutical \/ The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine","highestDevelopmentStatusID":"11","companyTruncated":"WanBangDe Pharmaceutical \/ The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine"},{"orgOrder":0,"company":"Aayush Wellness","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"INDIA","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Bacopa Monnieri","moa":"||Undisclosed","graph1":"Neurology","graph2":"Approved FDF","graph3":"Aayush Wellness","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Aayush Wellness \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Aayush Wellness \/ Undisclosed"},{"orgOrder":0,"company":"Cadila Pharmaceuticals","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"INDIA","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Benfotiamine | Pyridoxal 5-phosphate | L-Methyl Folate | Chromium Picolinate | Biotin | Vitamin B12","moa":"||Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Approved FDF","graph3":"Cadila Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Cadila Pharmaceuticals \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Cadila Pharmaceuticals \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals for Ginkgo Biloba

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          FNCE
                          Not Confirmed
                          FNCE
                          Not Confirmed

                          Lead Product(s) : Panax Ginseng Extract,Ginkgo Biloba,Benfotiamine | Pyridoxal 5-phosphate | L-Methyl Folate | Chromium Picolinate | Biotin | Vitamin B12

                          Therapeutic Area : Psychiatry/Psychology

                          Study Phase : Approved FDF

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Nu Nutridac, a clinically proven nutritional replenisher designed to support patients with neurodegenerative conditions and anxiety-related disorders.

                          Product Name : Nu Nutridac

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          September 16, 2025

                          Lead Product(s) : Panax Ginseng Extract,Ginkgo Biloba,Benfotiamine | Pyridoxal 5-phosphate | L-Methyl Folate | Chromium Picolinate | Biotin | Vitamin B12

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Approved FDF

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Aayush Wellness

                          Country arrow
                          FNCE
                          Not Confirmed

                          Aayush Wellness

                          Country arrow
                          FNCE
                          Not Confirmed

                          Details : Brain Fuel Capsules is formulated to support cognitive function, memory retention and mental clarity using time-tested herbal ingredients.

                          Product Name : Brain Fuel Capsules

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          July 14, 2025

                          Lead Product(s) : Bacopa Monnieri,Withanolide D,Ginkgo Biloba

                          Therapeutic Area : Neurology

                          Highest Development Status : Approved FDF

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          FNCE
                          Not Confirmed
                          FNCE
                          Not Confirmed

                          Lead Product(s) : Ginkgo Biloba

                          Therapeutic Area : Psychiatry/Psychology

                          Study Phase : Phase IV

                          Sponsor : The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Ginkgo Biloba is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Angina Pectoris-associated with Depression.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          August 27, 2020

                          Lead Product(s) : Ginkgo Biloba

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Phase IV

                          Sponsor : The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank